Oncogenic BRAF<sup>V600E</sup> inhibits BIM expression to promote melanoma cell survival
Robert A Cartlidge(Cancer Research Institute), Martin McMahon(University of Utah)
Cited by 116
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
|Science Translational Medicine|2010|185
p53 constrains progression to anaplastic thyroid carcinoma in a <i>Braf</i> -mutant mouse model of papillary thyroid cancer
|Proceedings of the National Academy of Sciences|2014|169
Isolation and Molecular Characterization of Circulating Melanoma Cells
|Cell Reports|2014|109